Showing results (901-910 of 926) with videos related to

Sort By:
Pageof 93
Journal of the American Geriatrics Society|April 20, 2010
Workshop on immunizations in older adults: identifying future research agendasKevin P High, Richard T D'Aquila, Rebecca A Fuldner, et al.
Human Vaccines & Immunotherapeutics|June 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trialsLidia Oostvogels, Thomas C Heineman, Robert W Johnson, et al.
The New England Journal of Medicine|April 20, 2022
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19Myron J Levin, Andrew Ustianowski, Stéphane De Wit, et al.
Memorias Do Instituto Oswaldo Cruz|May 5, 1998
Towards the physical map of the Trypanosoma cruzi nuclear genome: construction of YAC and BAC libraries of the reference clone T. cruzi CL-BrenerI Ferrari, H Lorenzi, M R Santos, et al.
American Journal of Hematology|October 26, 2021
Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosisEli Muchtar, Amber B Koehler, Michael J Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 23, 2014
Long-term persistence of zoster vaccine efficacyVicki A Morrison, Gary R Johnson, Kenneth E Schmader, et al.
International Journal for Parasitology|July 31, 2010
Trypanosoma cruzi I genotypes in different geographical regions and transmission cycles based on a microsatellite motif of the intergenic spacer of spliced-leader genesCarolina I Cura, Ana M Mejía-Jaramillo, Tomás Duffy, et al.
Cancer Research|January 8, 2011
Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapiesDana D Hu-Lowe, Enhong Chen, Lianglin Zhang, et al.
International Journal of Cancer|December 22, 2015
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE studyS Rachel Skinner, Cosette M Wheeler, Barbara Romanowski, et al.
The Oncologist|February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid TumorsSarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Pageof 93